WEINBERG URI (Chief Science Officer) sold 2.3% of their position (6.41K shares) of NOVOCURE LTD on the open market
Open‑market sale worth $85.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2026ACC: 0001811030-26-000003
Officer· Chief Science Officer
Since Apr 2020
+117.05K
Net shares
Net buyer
$85.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
123.47K acquired · 6.41K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+50.13K
Price / share
—
Trade value
—
% of position
22.4%
3/3/2026
223.48K→273.60K
Ordinary Shares
Direct
Shares
−6.41K
Price / share
$13.31
Trade value
$85.31K
% of position
2.3%
3/4/2026
273.60K→267.19K
Total
Net shares
+43.71K
Net value
-$85.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/3/2026 | A · Award | +50.13K | — | — | 22.4% | 223.48K | 273.60K |
| Ordinary Shares Direct | 3/4/2026 | S · Sale | −6.41K | $13.31 | $85.31K | 2.3% | 273.60K | 267.19K |
| Total | +43.71K | -$85.31K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
73.34K shares
Shares
+73.34K
Strike price
13.30
Held after
73.34K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares73.34K shares | 3/3/2026 | A · Award | +73.34K | 13.30 | — | 73.34K |